Combined, our data demonstrate the crucial role of GPR174 in regulating inflammation and endothelial cell survival after ischemic injury and identify Treg GPR174 as a potential therapeutic target for treating ischemic vascular diseases, such as PAD. This evidence concerns the gene GPR174 and peripheral arterial disease.